ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0NQJ Rtx A/s

184.60
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rtx A/s LSE:0NQJ London Ordinary Share DK0010267129 RTX ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 184.60 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Phone Comm Ex Radiotelephone 782.78M 46.72M 5.5167 33.46 1.56B

RTX signs strategic collaboration agreement for Healthcare solutions

30/11/2023 7:48am

GlobeNewswire Inc.


Rtx A/s (LSE:0NQJ)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Rtx A/s Charts.
RTX signs strategic collaboration agreement for Healthcare solutions

Nørresundby, Denmark, 30 November 2023 Announcement no. 18/2023

 

RTX has signed a firm agreement with a large global Healthcare company on a strategic collaboration to bring to market a new generation of Wireless Continuous Patient Monitoring infrastructure solutions for the Hospital Healthcare sector. This partnership is expected to result in new product announcements from the second half of 2024.

Healthcare is a segment, where RTX sees strong growth potential. Patients and providers in hospitals, elderly care centers, and other areas of healthcare benefit from mobility. This agreement we have signed, includes terms on intellectual property and sales/distribution channels. It will not affect RTX's outlook for 2023/24. However, it is an important milestone towards realizing our long-term ambition of reaching a revenue of more than DKK 1 billion and EBITDA margin above 16% in 2025/26.

Peter Røpke, CEO, RTX: "This collaboration agreement marks a significant step towards growth in our Healthcare segment. Through this strategic partnership, we will accelerate the introduction of new infrastructure products and expect our revenue in the Healthcare segment to grow by 100-200% by 2025/26”.

Questions and further information: CEO Peter Røpke, tel: +45 96 32 23 00RTX website: www.rtx.dk

 

Attachment

  • RTX CA No 18-2023 - 30.11.23 - Strategic collaboration agreement

1 Year Rtx A/s Chart

1 Year Rtx A/s Chart

1 Month Rtx A/s Chart

1 Month Rtx A/s Chart